tradingkey.logo

Virax Biolabs Group Ltd

VRAX
View Detailed Chart

0.860USD

+0.016+1.86%
Market hours ETQuotes delayed by 15 min
3.73MMarket Cap
--P/E TTM

Virax Biolabs Group Ltd

0.860

+0.016+1.86%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.86%

5 Days

-13.03%

1 Month

+1.18%

6 Months

-48.50%

Year to Date

-61.78%

1 Year

-23.89%

View Detailed Chart

Agency Rating

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(8)
Neutral(2)
Buy(1)
Indicators
Sell(2)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.030
Neutral
RSI(14)
43.057
Neutral
STOCH(KDJ)(9,3,3)
16.199
Oversold
ATR(14)
0.112
High Vlolatility
CCI(14)
-136.952
Sell
Williams %R
82.186
Oversold
TRIX(12,20)
0.324
Sell
StochRSI(14)
30.694
Buy
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
0.884
Sell
MA10
0.956
Sell
MA20
0.930
Sell
MA50
0.916
Sell
MA100
1.009
Sell
MA200
1.468
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing a T-Cell Test technologies with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against global viral threats. Its product portfolio includes ViraxClear and Virax Immune. ViraxClear offers a range of accurate diagnostic testing kits and machines. Virax Immune is a new Covid-19 test seeking detection of T-Cell immune responses to the SARS-Cov-2 virus. Its T-Cell testing is effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Monkeypox, Hepatitis B, Malaria, Herpes and Human Papillomavirus.
Ticker SymbolVRAX
CompanyVirax Biolabs Group Ltd
CEOMr. James Foster
Websitehttps://www.viraxbiolabs.com
KeyAI